Latest News & Research
- 2026-03-16SolutionsGBS Initiates Commercialization of Rapid Screening Products for Proteopathy.→
- 2026-03-16TechnologyProtein Structural Remediation Biomedicine→
- 2026-03-16PublicationsIncrease of HCN current in SOD1-associated amyotrophic lateral sclerosis→
- 2026-03-16ResourcesRestoring functional TDP-43 oligomers in ALS through baicalein-indu→
- 2026-03-16MediaBreaking Traditional Treatment! Graidit Unveils Baicalein Mechanism to Reverse Neurodegenerative Proteins in Dementia; Study Published in International Journal.→
- 2026-03-16TrialsInvitation for Participation in Clinical ResearchSoliciting Individuals Diagnosed with Early-Stage Dementia with Lewy Bodies (DLB) and Persons Aged 60 to 65 with a Familial History of Parkinson's Disease and Amyotrophic Lateral Sclerosis.→
- 2026-03-16PipelineGBS Leads the Way in Developing World's First Dual-Action Oral Drug for COVID-19 and Influenza.→
- 2026-03-16InsightsGood Prion, Bad Prion: TDP-43 Domain Plays Both Sides→
- 2026-03-16CorporateThe official website is newly launched, welcome your inquiries!→
TOP